Breaking News

Nighthawk Biosciences’ Scorpion Subsidiary Hosts Grand Opening of San Antonio Facility

Will provide Scorpion with substantial biomanufacturing capabilities to accommodate future worldwide demand for biologic manufacturing.

Author Image

By: Charlie Sternberg

Associate Editor

NightHawk Biosciences’ Scorpion subsidiary hosted the grand opening of its San Antonio facility on October 21.   David Halverson, president of Scorpion, commented, “We are pleased with the recent FDA feedback regarding our design, operational strategy, and environmental controls relevant to clinical and commercial manufacturing at our San Antonio facility. In addition, the planning for our new facility in Manhattan, Kansas continues to progress. These two facilities, once fully operational, wi...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters